Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Other Non-Current Assets (2016 - 2025)

Arcadia Biosciences' Other Non-Current Assets history spans 12 years, with the latest figure at $143000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 48.96% year-over-year to $143000.0; the TTM value through Dec 2025 reached $143000.0, up 48.96%, while the annual FY2025 figure was $143000.0, 48.96% up from the prior year.
  • Other Non-Current Assets reached $143000.0 in Q4 2025 per RKDA's latest filing, down from $148000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.5 million in Q4 2023 to a low of $23000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $320666.7, with a median of $164500.0 recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: surged 14366.67% in 2023, then tumbled 97.24% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $180000.0 in 2021, then tumbled by 86.67% to $24000.0 in 2022, then soared by 14366.67% to $3.5 million in 2023, then crashed by 97.24% to $96000.0 in 2024, then surged by 48.96% to $143000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Other Non-Current Assets are $143000.0 (Q4 2025), $148000.0 (Q3 2025), and $96000.0 (Q1 2025).